Lv22
120 积分 2024-06-28 加入
Low‐Dose Versus High‐Dose Lenvatinib in Radioiodine Refractory Differentiated Thyroid Cancer—A Real‐World Safety and Efficacy Analysis
1天前
待确认
A phase II study of the halichondrin B analog eribulin mesylate in gemcitabine refractory advanced pancreatic cancer
12天前
已关闭
卵巢恶性肿瘤患者诊治中的抗凝问题
19天前
已完结
Expression of vascular endothelial growth factor and its receptors KDR and Flt-1 in gastric cancer cells
19天前
已完结
Clinical Outcomes of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers
1个月前
已完结
Survival Prognostication in Patients with Differentiated Thyroid Cancer and Distant Metastases: A SEER Population-Based Study
1个月前
已完结
Liver transplantation as an alternative for the treatment of perihilar cholangiocarcinoma: A critical review
1个月前
已完结
Hallmarks of Cancer: New Dimensions
1个月前
已完结
Molecular targets of tyrosine kinase inhibitors in thyroid cancer
1个月前
已完结
Genomic alterations in thyroid cancer: biological and clinical insights
1个月前
已完结
皖公网安备34019202002308
